Kara Trainor composed herself, looked into a camera and began to speak to the drugmakers she holds responsible for two decades of suffering that has extended from her to a son born dependent on opioids.
Three members of the family that owns OxyContin maker Purdue Pharma watched silently or listened to the virtual court hearing as Trainor described giving birth to a baby who rapidly plunged into withdrawal — “the screaming will haunt you for the rest of your life” — and what it's been like to raise him. At 11, he still uses a sippy cup and diapers.
